Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malaria

  Free Subscription


Articles published in J Infect Dis

Retrieve available abstracts of 81 articles:
HTML format
Text format



Single Articles


    June 2017
  1. CATOR L
    Editorial: Host Attractiveness and Malaria Transmission to Mosquitoes.
    J Infect Dis. 2017 Jun 13. doi: 10.1093.
    PubMed     Text format    


  2. FAIK I, van Tong H, Lell B, Meyer CG, et al
    Pyruvate kinase and Fc gamma receptor gene copy numbers associated with malaria phenotypes.
    J Infect Dis. 2017 Jun 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. BEI AK, Ahouidi AD, Dvorin JD, Miura K, et al
    Functional analysis reveals geographical variation in inhibitory immune responses against a polymorphic malaria antigen.
    J Infect Dis. 2017 Jun 9. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2017
  4. SEPULVEDA N, Manjurano A, Campino SG, Lemnge M, et al
    Malaria host candidate genes validated by association with current, recent and historic measures of transmission intensity.
    J Infect Dis. 2017 May 25. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2017
  5. GATTON ML, Dunn J, Chaudhry A, Ciketic S, et al
    Use of PfHRP2-only RDTs rapidly select for PfHRP2-negative parasites with serious implications for malaria case management and control.
    J Infect Dis. 2017 Mar 8. doi: 10.1093.
    PubMed     Text format     Abstract available


  6. LO E, Lam N, Hemming-Schroeder E, Nguyen J, et al
    Frequent Spread of Plasmodium vivax Malaria Maintains High Genetic Diversity at the Myanmar-China Border without Distance and Landscape Barriers.
    J Infect Dis. 2017 Mar 3. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2017
  7. TER KUILE FO, Taylor SM
    Gilding the lily?: Enhancing antenatal malaria prevention in HIV-infected women.
    J Infect Dis. 2017 Feb 28. doi: 10.1093.
    PubMed     Text format    


  8. NATUREEBA P, Kakuru A, Muhindo M, Littmann E, et al
    Intermittent Preventive Treatment with Dihydroartemisinin-piperaquine for the Prevention of Malaria among HIV-infected Pregnant Women.
    J Infect Dis. 2017 Feb 22. doi: 10.1093.
    PubMed     Text format     Abstract available


  9. KANA IH, Adu B, Tiendrebeogo RW, Singh SK, et al
    Naturally Acquired Antibodies Target the Glutamate-Rich Protein on Intact Merozoites and Predict Protection Against Febrile Malaria.
    J Infect Dis. 2017 Feb 21. doi: 10.1093.
    PubMed     Text format     Abstract available


  10. TUMWEBAZE P, Tukwasibwe S, Taylor A, Conrad M, et al
    Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.
    J Infect Dis. 2017;215:631-635.
    PubMed     Text format     Abstract available


  11. LUBIS IN, Wijaya H, Lubis M, Lubis CP, et al
    Contribution of Plasmodium knowlesi to multi-species human malaria infections in North Sumatera, Indonesia.
    J Infect Dis. 2017 Feb 13. doi: 10.1093.
    PubMed     Text format    


  12. MIRA-MARTINEZ S, van Schuppen E, Amambua-Ngwa A, Bottieau E, et al
    Expression of the Plasmodium falciparum Clonally Variant clag3 Genes in Human Infections.
    J Infect Dis. 2017 Feb 7. doi: 10.1093.
    PubMed     Text format     Abstract available


    January 2017
  13. HOBBS CV, Anderson C, Neal J, Sahu T, et al
    Trimethoprim-Sulfamethoxazole Prophylaxis During Live Malaria Sporozoite Immunization Induces Long-Lived, Homologous, and Heterologous Protective Immunity Against Sporozoite Challenge.
    J Infect Dis. 2017;215:122-130.
    PubMed     Text format     Abstract available


  14. OTTICHILO RK, Polyak CS, Guyah B, Singa B, et al
    Malaria Parasitemia and Parasite Density in Antiretroviral-Treated HIV-Infected Adults Following Discontinuation of Cotrimoxazole Prophylaxis.
    J Infect Dis. 2017;215:88-94.
    PubMed     Text format     Abstract available


    December 2016
  15. THOMSEN EK, Koimbu G, Pulford J, Jamea-Maiasa S, et al
    Mosquito behaviour change after distribution of bednets results in decreased protection against malaria exposure.
    J Infect Dis. 2016 Dec 22. pii: jiw615. doi: 10.1093.
    PubMed     Text format     Abstract available


  16. ALKAITIS MS, Wang H, Ikeda AK, Rowley CA, et al
    Decreased Rate of Plasma Arginine Appearance in Murine Malaria May Explain Hypoargininemia in Children With Cerebral Malaria.
    J Infect Dis. 2016;214:1840-1849.
    PubMed     Text format     Abstract available


  17. EISELE TP, Bennett A, Silumbe K, Finn TP, et al
    Short-term Impact of Mass Drug Administration With Dihydroartemisinin Plus Piperaquine on Malaria in Southern Province Zambia: A Cluster-Randomized Controlled Trial.
    J Infect Dis. 2016;214:1831-1839.
    PubMed     Text format     Abstract available


  18. CHEN I, Gosling R, Drakeley C, Bousema T, et al
    Mass Drug Administration for Malaria: A Means to What end?
    J Infect Dis. 2016;214:1790-1792.
    PubMed     Text format    


  19. YA-UMPHAN P, Cerqueira D, Parker DM, Cottrell G, et al
    Anopheles Salivary Biomarker to Assess Malaria Transmission Risk Along the Thailand-Myanmar Border.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    November 2016
  20. SILTERRA J, Gillette MA, Lanaspa M, Pelle KG, et al
    Transcriptional categorization of the etiology of pneumonia syndrome in pediatric patients in malaria endemic areas.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    September 2016
  21. HOU N, Zou Y, Piao X, Liu S, et al
    T Cell Immunoglobulin- and Mucin-Domain-Containing Molecule-3 (Tim-3) Signalling Blockade Improves Cell-Mediated Immunity Against Malaria.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  22. PETERSON I, Bar-Zeev N, Kennedy N, Ho A, et al
    Respiratory virus-associated severe acute respiratory illness (SARI) and viral clustering in Malawian children in a setting with a high prevalence of HIV, malaria and malnutrition.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  23. BARBER BE, William T, Grigg MJ, Piera KA, et al
    Nitric oxide dependent endothelial dysfunction and reduced arginine bioavailability in vivax malaria but no greater increase in intravascular haemolysis in severe disease.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    August 2016
  24. NICOLETE VC, Frischmann S, Barbosa S, King CL, et al
    Naturally Acquired Binding-Inhibitory Antibodies to Plasmodium vivax Duffy Binding Protein Are Associated with Clinical Immunity to Malaria in Rural Amazonians.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  25. REYNALDI A, Schlub TE, Piriou E, Ogolla S, et al
    Modeling of EBV infection and antibody responses in Kenyan infants with different levels of malaria exposure shows maternal antibody decay is a major determinant of early EBV infection.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  26. BOYCE R, Reyes R, Matte M, Ntaro M, et al
    Severe flooding and malaria transmission in the Western Ugandan highlands: Implications for disease control in an era of global climate change.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  27. ELPHINSTONE RE, Conroy AL, Hawkes M, Hermann L, et al
    Alterations in systemic extracellular heme and hemopexin are associated with adverse clinical outcomes in Ugandan children with severe malaria.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  28. BRIAND V, Saal J, Ghafari C, Huynh BT, et al
    Fetal Growth Restriction Is Associated With Malaria in Pregnancy: A Prospective Longitudinal Study in Benin.
    J Infect Dis. 2016;214:417-25.
    PubMed     Text format     Abstract available


  29. RODRIGUEZ-BARRAQUER I, Arinaitwe E, Jagannathan P, Boyle MJ, et al
    Quantifying heterogeneous malaria exposure and clinical protection in a cohort of Ugandan children.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    July 2016
  30. TCHAPARIAN E, Sambol NC, Arinaitwe E, McCormack SA, et al
    Population pharmacokinetics and pharmacodynamics of lumefantrine in young Ugandan children treated with artemether-lumefantrine for uncomplicated malaria.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    June 2016

  31. Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01.
    J Infect Dis. 2016.
    PubMed     Text format    


  32. RAMPLING T, Ewer KJ, Bowyer G, Bliss CM, et al
    Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B with ChAd-MVA Vectored Vaccines Expressing ME-TRAP.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  33. REGULES JA, Cicatelli SB, Bennett JW, Paolino KM, et al
    Fractional third and fourth dose of RTS,S/AS01 malaria candidate vaccine: a phase 2a controlled human malaria infection and immunogenicity study.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    May 2016
  34. DORITCHAMOU JY, Herrera R, Aebig JA, Morrison R, et al
    VAR2CSA domain-specific analysis of naturally acquired functional antibodies to P. falciparum placental malaria.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    March 2016
  35. BECK HP, Wampfler R, Carter N, Koh G, et al
    Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping.
    J Infect Dis. 2016;213:794-9.
    PubMed     Text format     Abstract available


    February 2016
  36. KATRAK S, Day N, Ssemmondo E, Kwarisiima D, et al
    Community-wide prevalence of malaria parasitemia in HIV-infected and uninfected populations in a high transmission setting in Uganda.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  37. GONCALVES BP, Drakeley C, Bousema T
    Infectivity of microscopic and submicroscopic malaria infections in low endemic settings.
    J Infect Dis. 2016.
    PubMed     Text format    


  38. LIN JT, Meshnick SR, Saunders DL, Lon C, et al
    Infectivity of microscopic and submicroscopic malaria infections in low endemic settings.
    J Infect Dis. 2016.
    PubMed     Text format    


  39. PAYNE RO, Milne KH, Elias SC, Edwards NJ, et al
    Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  40. GUTMAN J, Taylor S, Meshnick SR, Ter Kuile FO, et al
    Reply to Harrington et al.
    J Infect Dis. 2016;213:497-8.
    PubMed     Text format    


  41. HARRINGTON WE, Fried M, Duffy PE
    Defending the Use of Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment for Malaria in Pregnancy: A Short-Sighted Strategy.
    J Infect Dis. 2016;213:496-7.
    PubMed     Text format    


    December 2015
  42. CHENET SM, Akinyi Okoth S, Huber CS, Chandrabose J, et al
    Independent Emergence of the Plasmodium Falciparum Kelch Propeller Domain Mutant Allele C580Y in Guyana.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  43. IMWONG M, Stepniewska K, Tripura R, Peto TJ, et al
    The numerical distributions of parasite densities in asymptomatic malaria.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  44. GOVINDASAMY G, Barber BE, Ghani SA, William T, et al
    Retinal changes in uncomplicated and severe Plasmodium knowlesi malaria.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  45. FARRINGTON LA, Jagannathan P, McIntyre TI, Vance HM, et al
    Frequent malaria drives progressive Vdelta2 T cell loss, dysfunction, and CD16 upregulation during early childhood.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  46. LIN JT, Ubalee R, Lon C, Balasubramanian S, et al
    Microscopic Plasmodium falciparum gametocytemia and infectivity to mosquitoes in Cambodia.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  47. URSING J, Rombo L, Bergqvist Y, Rodrigues A, et al
    High dose chloroquine can be used for treatment of chloroquine resistant Plasmodium falciparum malaria.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  48. STRESMAN GH, Baidjoe AY, Stevenson J, Grignard L, et al
    Focal Screening to Identify the Subpatent Parasite Reservoir in an Area of Low and Heterogeneous Transmission in the Kenya Highlands.
    J Infect Dis. 2015;212:1768-77.
    PubMed     Text format     Abstract available


    November 2015
  49. YEKA A, Kigozi R, Conrad MD, Lugemwa M, et al
    Artesunate/amodiaquine versus artemether/lumefantrine for the treatment of uncomplicated malaria in Uganda: a randomized trial.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  50. REYNALDI A, Schlub TE, Chelimo K, Sumba PO, et al
    The impact of malaria co-infections on longitudinal Epstein-Barr virus kinetics in Kenyan children.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    October 2015
  51. VAN SCHALKWYK DA, Nash MN, Shafik SH, Summers RL, et al
    Verapamil-sensitive transport of quinacrine and methylene blue via mutant PfCRT reduces the malaria parasite's susceptibility to these tricyclic drugs.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  52. ISHIOKA H, Ghose A, Charunwatthana P, Maude R, et al
    Sequestration and Red Cell Deformability as determinants of hyperlactataemia in falciparum malaria.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  53. FORNACE KM, Nuin NA, Betson M, Grigg MJ, et al
    Asymptomatic and submicroscopic carriage of Plasmodium knowlesi malaria in household and community members of clinical cases in Sabah, Malaysia.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    September 2015
  54. LIN JT, Hathaway NJ, Saunders DL, Lon C, et al
    Using Amplicon Deep Sequencing to Detect Genetic Signatures of Plasmodium vivax Relapse.
    J Infect Dis. 2015;212:999-1008.
    PubMed     Text format     Abstract available


  55. MEJIA P, Diez-Silva M, Kamena F, Lu F, et al
    Human C1-Inhibitor suppresses malaria parasite invasion and cytoadhesion via binding to parasite glycosylphosphatidylinositol and host cell receptors.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  56. ARTIMOVICH E, Schneider K, Taylor TE, Kublin JG, et al
    Persistence of Sulfadoxine-Pyrimethamine Resistance Despite Reduction of Drug Pressure in Malawi.
    J Infect Dis. 2015;212:694-701.
    PubMed     Text format     Abstract available


    August 2015
  57. -ASCOFARE OM, May J
    Is A578S SNP in K13-propeller a marker of emerging Plasmodium falciparum artemisinin-resistance in Africa?
    J Infect Dis. 2015.
    PubMed     Text format    


  58. ATWELL JE, Thumar B, Robinson LJ, Tobby R, et al
    Impact of placental malaria and hypergammaglobulinemia on transplacental transfer of respiratory syncytial virus antibody in Papua New Guinea.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    July 2015
  59. KEPHA S, Nuwaha F, Nikolay B, Gichuki P, et al
    Effect of repeated anthelminthic treatment on malaria in school children in Kenya: a randomized, open label, equivalence trial.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  60. OUEDRAOGO AL, Goncalves BP, Gneme A, Wenger EA, et al
    Dynamics of the human infectious reservoir for malaria determined by mosquito feeding assays and ultra-sensitive malaria diagnosis in Burkina Faso.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  61. ZHANG R, Suwanarusk R, Malleret B, Cooke BM, et al
    A basis for rapid clearance of circulating ring-stage malaria parasites by the spiroindolone KAE609.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  62. YEO TW, Anstey NM
    Reply to Eisenhut.
    J Infect Dis. 2015;212:168.
    PubMed     Text format    


    May 2015
  63. COSTA PA, Leoratti FM, Figueiredo MM, Tada MS, et al
    Induction of inhibitory receptors on T cells during Plasmodium vivax malaria impairs cytokine production.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  64. TRAVASSOS MA, Coulibaly D, Laurens MB, Dembele A, et al
    Hemoglobin C trait provides protection from clinical falciparum malaria in Malian children.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  65. DAUD II, Coleman CB, Smith NA, Ogolla S, et al
    Breast-Milk as a Potential Source of Epstein-Barr Virus Transmission among Infants Living in a Malaria Endemic Region of Kenya.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  66. BERG A, Otterdal K, Patel S, Gonca M, et al
    Complement activation correlates to disease severity and contribute to cytokine response in falciparum malaria.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  67. HSIANG MS, Greenhouse B, Rosenthal PJ
    Reply to Goyal et al.
    J Infect Dis. 2015;211:1687.
    PubMed     Text format    


    April 2015
  68. HUANG F, Takala-Harrison S, Jacob CG, Liu H, et al
    A single mutation in K13 predominates in Southern China and is associated with delayed clearance of Plasmodium falciparum following artemisinin treatment.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  69. MENSAH-BROWN HE, Amoako N, Abugri J, Stewart LB, et al
    Analysis of erythrocyte invasion mechanisms of Plasmodium falciparum clinical isolates across three endemic areas within one country.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  70. ZEESHAN M, Tyagi RK, Tyagi K, Alam MS, et al
    Host-parasite interaction: selective Pv-fam-a family proteins of Plasmodium vivax bind to a restricted number of human erythrocyte receptors.
    J Infect Dis. 2015;211:1111-20.
    PubMed     Text format     Abstract available


    March 2015
  71. BERNA AZ, McCarthy JS, Wang XR, Saliba KJ, et al
    Biomarkers of infection with Plasmodium falciparum detected in human breath.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  72. ESPINOSA DA, Gutierrez GM, Rojas-Lopez M, Noe AR, et al
    Proteolytic Cleavage of the P. falciparum Circumsporozoite Protein is a Target of Protective Antibodies.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    February 2015
  73. MANGANO VD, Kabore Y, Bougouma EC, Verra F, et al
    Novel insights into the protective role of haemoglobin S and C against Plasmodium falciparum parasitaemia.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  74. HUSON MA, Wouters D, van Mierlo G, Grobusch MP, et al
    HIV co-infection enhances complement activation during sepsis.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  75. BOYLE MJ, Jagannathan P, Bowen K, McIntyre TI, et al
    The effector phenotype of P. falciparum-specific CD4 T cells is influenced by both age and transmission intensity in naturally exposed populations.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    January 2015
  76. GUTMAN J, Kalilani L, Taylor S, Zhou Z, et al
    Plasmodium falciparum dihydropteroate synthetase-A581G mutation reduces effectiveness of sulfadoxine-pyrimethamine preventive therapy in Malawian pregnant women.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    November 2014
  77. TORRES KJ, Castrillon CE, Moss EL, Saito M, et al
    Genome-Level Determination of Plasmodium falciparum Blood Stage Targets of Malarial Clinical Immunity in the Peruvian Amazon.
    J Infect Dis. 2014.
    PubMed     Text format     Abstract available


  78. KAMAU E, Campino S, Amenga-Etego L, Drury E, et al
    K13-propeller polymorphisms in Plasmodium falciparum parasites from sub-Saharan Africa.
    J Infect Dis. 2014.
    PubMed     Text format     Abstract available


    October 2014
  79. GULLINGSRUD J, Milman N, Saveria T, Chesnokov O, et al
    High throughput screening platform identifies small molecules that prevent sequestration of Plasmodium falciparum-infected erythrocytes.
    J Infect Dis. 2014.
    PubMed     Text format     Abstract available


  80. LUKENS AK, Heidebrecht RW Jr, Mulrooney C, Beaudoin JA, et al
    Diversity-Oriented Synthesis probe targets Plasmodium falciparum cytochrome b ubiquinone reduction site and synergizes with oxidation site inhibitors.
    J Infect Dis. 2014.
    PubMed     Text format     Abstract available


  81. OBALDIA N 3RD, Baro NK, Calzada JE, Santamaria AM, et al
    Clonal outbreak of Plasmodium falciparum in eastern Panama.
    J Infect Dis. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malaria is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: